AGT and triple-A syndrome: Moreover, JAK2V617F is the most common driving mutation in myeloproliferative neoplasms, which can accelerate Ang II‐induced AAA formation by promoting macrophage infiltration and the secretion of Mmp‐2, ‐9, and ‐13.156